Inventor
NEEF GUENTER
DE43 patents
⚠️ This page may combine multiple inventors who share the name “NEEF GUENTER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING AG
39 patentsUS5446035AAug 29, 1995
20-methyl-substituted vitamin D derivatives
SCHERING AG79 citations96
US5089488AFeb 18, 1992
β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same
SCHERING AG44 citations96
US4814327AMar 21, 1989
11 β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same
SCHERING AG49 citations96
US5411949AMay 2, 1995
23-oxa-derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use pharmaceutical agents
SCHERING AG55 citations95
US4435403AMar 6, 1984
Pharmacologically active 3-substituted beta-carbolines
SCHERING AG46 citations95
US4780461AOct 25, 1988
13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
SCHERING AG32 citations93
US6531459B1Mar 11, 2003
Vitamin D derivatives with phosphorus atoms in the side chains
SCHERING AG28 citations92
US6376480B1Apr 23, 2002
Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents
SCHERING AG18 citations92
US6372731B1Apr 16, 2002
Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments
SCHERING AG21 citations92
US5843933ADec 1, 1998
11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
SCHERING AG31 citations92
US5728689AMar 17, 1998
11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
SCHERING AG18 citations92
US5663157ASep 2, 1997
22-en-25-oxa derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use as pharmaceutical agents
SCHERING AG25 citations92
US5583125ADec 10, 1996
25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents
SCHERING AG37 citations92
US5446036AAug 29, 1995
13-alkyl-11beta-phenylgonanes
SCHERING AG32 citations92
US5273971ADec 28, 1993
13-alkyl-11β-phenylgonanes
SCHERING AG26 citations92
US4829060AMay 9, 1989
11 Beta-N,N-dimethylaminophenyl-estradienes, their manufacture and pharmaceutical preparations containing them
SCHERING AG32 citations92
US4536401AAug 20, 1985
11β-aryl estradienes, processes for their production and pharmaceutical preparations containing them
SCHERING AG29 citations92
US4870069ASep 26, 1989
11β-alkynyl-estrenes and -estradienes, their production and pharmaceutical preparations containing them
SCHERING AG27 citations91
US5089635AFeb 18, 1992
11 β-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
SCHERING AG25 citations90
US5426102AJun 20, 1995
14β-H-, 14-and 15-En-11β-aryl-4-oestrenes
SCHERING AG20 citations83
US5132299AJul 21, 1992
11β-phenyl-4,9,15-estratrienes, their manufacture and pharmaceutical preparations containing same
SCHERING AG21 citations82
US4596808AJun 24, 1986
Pharmacologically active 3-substituted beta-carbolines useful as tranquilizers
SCHERING AG24 citations81
US6642218B2Nov 4, 2003
Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments
SCHERING AG7 citations73
US6613920B1Sep 2, 2003
Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents
SCHERING AG4 citations73
US5093507AMar 3, 1992
10β,11β-bridged steroids
SCHERING AG15 citations73
US7211680B2May 1, 2007
Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments
SCHERING AG4 citations71
US6025507AFeb 15, 2000
Borneol derivatives, methods of manufacturing them, and their pharmaceutical use
SCHERING AG14 citations69
US5478956ADec 26, 1995
8-En-19 11 β-bridged steroids, their production and pharmaceutical preparations containing them
SCHERING AG16 citations68
US4066674AJan 3, 1978
Process for the preparation of 1,3-oxygenated 8α-estratrienes and novel intermediates obtained therefrom
SCHERING AG6 citations63
US5134136AJul 28, 1992
14α,17α-ethanoestratrienes
SCHERING AG4 citations62
US4333928AJun 8, 1982
16 α-Alkyl steroids, their preparation, and pharmaceutical preparations thereof
SCHERING AG3 citations62
US5792792AAug 11, 1998
Borenol derivatives, process for their production and their pharmaceutical use
SCHERING AG2 citations61
US4870067ASep 26, 1989
Oxytocins and antigestagens in combination for induction of birth
SCHERING AG2 citations58
US6596713B1Jul 22, 2003
Steroid esters and amides, process for their production and their pharmaceutical use
SCHERING AG2 citations57
US4843157AJun 27, 1989
13alpha-alkylgonan-delta 9(11)-5,10-epoxides
SCHERING AG5 citations54
US4603013AJul 29, 1986
Estrane derivatives
SCHERING AG1 citations52
US4298538ANov 3, 1981
16-Dimethylaminomethylene-3-methoxy-1,3,5-(10)-estratrien-17-one, a process for the preparation thereof and its use as a preparative intermediate
SCHERING AG1 citations52
US5965609AOct 12, 1999
Borneol esters, process for their production, and their pharmaceutical use
SCHERING AG1 citations51
US5529993AJun 25, 1996
14α, 17α-ethano-16α-hydroxy-estratrienes
SCHERING AG0 citations51